Shilpa Medicare Limited (NSE:SHILPAMED)
822.60
+15.05 (1.86%)
Aug 11, 2026, 3:30 PM IST
Shilpa Medicare Revenue
Shilpa Medicare had revenue of 4.66B INR in the quarter ending June 30, 2026, with 44.90% growth. This brings the company's revenue in the last twelve months to 16.83B, up 27.96% year-over-year. In the fiscal year ending March 31, 2026, Shilpa Medicare had annual revenue of 15.39B with 19.49% growth.
Revenue (ttm)
16.83B
Revenue Growth
+27.96%
P/S Ratio
9.38
Revenue / Employee
16.87M
Employees
998
Market Cap
157.95B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 15.39B | 2.51B | 19.49% |
| Mar 31, 2025 | 12.88B | 1.35B | 11.69% |
| Mar 31, 2024 | 11.53B | 1.01B | 9.64% |
| Mar 31, 2023 | 10.52B | -952.56M | -8.31% |
| Mar 31, 2022 | 11.47B | 2.45B | 27.21% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Piramal Pharma | 92.05B |
| Alembic Pharmaceuticals | 77.84B |
| Strides Pharma Science | 50.04B |
| Akums Drugs and Pharmaceuticals | 45.08B |
| NATCO Pharma | 40.78B |
| Wockhardt | 34.62B |
| Eris Lifesciences | 32.12B |
| Alivus Life Sciences | 25.90B |
Shilpa Medicare News
- 6 weeks ago - Shilpa Medicare partners with Orion for nivolumab biosimilar development in Europe - Business Upturn
- 6 weeks ago - Shilpa Medicare commissions state-of-the-art ADC manufacturing facility - Business Upturn
- 2 months ago - Shilpa Medicare and Gate2brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy - Business Upturn
- 2 months ago - Shilpa Medicare subsidiary invests €7 million for 30.4% stake in Gate2Brain - Business Upturn
- 2 months ago - Shilpa Medicare Q4 Results: Net profit jumps over 7x to Rs 108 crore, revenue up 32% - Business Upturn
- 4 months ago - Pharma sector stocks today, April 6: Shilpa Medicare down 3.07%, Ipca Labs decline 2.42%, Sun Pharma falls 1.42% - Business Upturn
- 5 months ago - Pharma sector stocks today, March 24: Shilpa Medicare jumps 3.28%, Glenmark Pharma up 1.36%, Laurus Labs gain 1.65% - Business Upturn
- 5 months ago - Pharma sector stocks today, March 6: Shilpa Medicare surge 3.08%, Wockhardt jumps 2.12%, Natco Pharma up 1.84%, - Business Upturn